Clinical trial
Multicentric Clinical Study to Determine Safety and Efficacy of a Hydrophobic Acrylic Trifocal Intraocular Lens (IOL)
NCT04465344 is registered in ClinicalTrials.gov with Cutting Edge SAS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicentric Clinical Study to Determine Safety and Efficacy of a Hydrophobic Acrylic Trifocal Intraocular Lens (IOL)
- Lead sponsor
- Cutting Edge SAS
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2021
- Completion date
- June 27, 2024
- Enrollment
- 188 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
cataract, lens opacities